Boston Scientific recently announced results from the first clinical trial evaluating the performance of the HeartLogic Heart Failure Diagnostic Service to predict impending heart failure (HF) decompensation. Data collected from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study were presented as a late-breaking clinical trial at the American Heart Association (AHA) Scientific Sessions 2016, Nov. 12-16 in New Orleans, and confirmed the HeartLogic alert provided a highly sensitive and timely predictor of a future HF event.

Depression has been known to be associated with poor cardiovascular outcomes. But if patients who are depressed attend cardiac rehabilitation after heart surgery, their risk of death is significantly reduced, according to a new study.

Computational Signal Detection (CSD) Laboratories LLC announced the publication of data in support of the clinical utility of its eMurmur computer-aided auscultation (CAA) platform for early and ongoing heart-health screening of children.

Many people who experience chest pain but don’t have a heart attack breathe a big sigh of relief when a stress test comes back negative for blockages in their blood vessels. But a new study by cardiac researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found they may not be off the hook after all.